FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

Fourth Quarter Performance Report
October 14, 2021

Released for the
2020-21 Fiscal Year Continue reading


Topical Ocular Pharmaceutical Agents added to Formulary
September 1, 2021

The Board of Optometry has added the following Topical Ocular Pharmaceutical Agents to the formulary… Continue reading